Tonix pharmaceuticals holding corp. (TNXP)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
COSTS AND EXPENSES:
Research and development

4,676

5,690

5,052

3,554

3,896

5,057

3,264

4,067

5,170

3,634

3,908

2,806

2,994

4,880

5,466

7,516

10,671

9,490

10,314

8,871

6,829

5,775

5,217

4,075

3,550

1,328

1,637

944

741

870

658

658

397

523

492

63

79

-

-

General and administrative

2,621

3,044

2,839

2,352

2,401

2,593

2,277

2,076

1,818

1,909

1,927

2,016

2,097

2,630

2,143

2,320

3,343

3,912

2,966

2,913

2,867

3,229

2,217

1,974

1,619

2,381

1,455

1,142

1,260

1,162

1,076

1,076

762

970

522

292

434

2

0

Total costs and expenses

7,297

8,734

7,891

5,906

6,297

7,650

5,541

6,143

6,988

5,543

5,835

4,822

5,091

7,510

7,609

9,836

14,014

-

13,280

11,784

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,696

9,004

7,434

6,049

5,169

3,709

3,092

2,086

2,001

2,032

1,734

1,734

1,160

1,494

1,014

355

513

-

-

Operating Loss

-7,297

-8,734

-7,891

-5,906

-6,297

-7,650

-5,541

-6,143

-6,988

-5,543

-5,835

-4,822

-5,091

-7,510

-7,609

-9,836

-14,014

-13,402

-13,280

-11,784

-9,696

-9,004

-7,434

-6,049

-5,169

-3,709

-3,092

-2,086

-2,001

-2,032

-1,734

-1,734

-1,160

-1,494

-1,014

-355

-513

-

-

Interest income, net

24

27

53

66

64

62

62

56

53

50

49

42

27

28

31

30

38

42

30

21

15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

-

-

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

1

1

0

-

0

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1,224

0

0

47

-

0

-

0

-

-

Interest income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

15

5

5

2

2

0

0

-712

0

0

-901

-

0

0

-

-

-

Interest and other financing costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

-

-

Mineral Property Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Professional Fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

1

Net loss

-7,273

-8,707

-7,838

-5,840

-6,233

-7,588

-5,479

-6,087

-6,935

-5,493

-5,786

-4,780

-5,064

-7,482

-7,578

-9,806

-13,976

-13,360

-13,250

-11,763

-9,681

-8,989

-7,419

-6,044

-5,164

-3,707

-3,090

-2,086

-2,001

-3,970

-1,732

-1,732

-2,014

-1,586

-1,014

-355

-513

-3

-2

Warrant deemed dividend

451

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock deemed dividend

1,260

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss available to common stockholders

-8,984

-

-

-

-6,233

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per common share, basic and diluted (in dollars per share)

-0.37

0.07

-5.69

-0.95

-12.76

-188.83

-54.99

-7.23

-8.80

-29.00

-0.77

-0.65

-1.27

-0.13

-2.90

-4.97

-7.41

-26.46

-0.72

-0.73

-0.71

-0.86

-0.71

-0.61

-0.59

-0.62

-0.87

-0.95

-0.93

-3.25

-0.05

-1.01

-1.27

-3.14

-0.05

-0.02

-0.03

0.00

0.00

Weighted average common shares outstanding, basic and diluted (in shares)

24,028

-1,598

1,377

6,167

488

-1,277

99

842

787

-16,155

7,508

7,327

3,985

3,611

2,613

1,973

1,886

-41,541

18,423

16,137

13,696

10,804

10,496

9,923

8,718

5,042

3,537

2,186

2,159

-30,801

34,278

1,713

1,582

-

20,667

19,716

-

-

-

Weighted average common shares outstanding, basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,657

-

-

Weighted average number of common shares outstanding

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,500

5,500